STOCK TITAN

Billionaire Israel Englander's Fund Builds Major Position in Biotech Ardelyx

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Millennium Management LLC, along with affiliated entities, has reported acquiring a significant stake in Ardelyx. According to the Schedule 13G filing dated June 28, 2025, the reporting persons collectively own 12,099,947 shares, representing a 5.1% ownership in the company.

The reporting persons include:

  • Millennium Management LLC (Delaware)
  • Millennium Group Management LLC (Delaware)
  • Israel A. Englander (United States)

All three parties share voting and dispositive power over the reported shares, with no sole voting or dispositive power. The securities were not acquired for the purpose of changing or influencing control of Ardelyx. The shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander.

Positive

  • Millennium Management LLC and related entities have acquired a significant 5.1% stake (12,099,947 shares) in Ardelyx, indicating institutional confidence in the company

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/24/2025
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:06/24/2025
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:06/24/2025
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of June 24, 2025, by and among Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

How many shares of ARDX does Millennium Management LLC own as of June 2025?

According to the Schedule 13G filing, Millennium Management LLC beneficially owns 12,099,947 shares of Ardelyx, Inc. (ARDX) common stock with shared voting and dispositive power.

What percentage of ARDX stock does Millennium Management LLC control?

Millennium Management LLC controls 5.1% of Ardelyx, Inc.'s (ARDX) outstanding common stock, as reported in their June 2025 Schedule 13G filing.

Who are the reporting persons in ARDX's June 2025 13G filing?

The reporting persons in the 13G filing are: 1) Millennium Management LLC, 2) Millennium Group Management LLC, and 3) Israel A. Englander. All three entities report beneficial ownership of the same 12,099,947 shares.

What is the purpose of Millennium Management LLC's investment in ARDX?

According to the certification in Item 10 of the filing, the shares were not acquired to change or influence control of Ardelyx (ARDX). The investment is not held in connection with any transaction to affect control of the company.

When did Millennium Management LLC's ownership in ARDX trigger this 13G filing?

The event that triggered this Schedule 13G filing occurred on June 17, 2025, as indicated in the initial section of the filing. The document was subsequently filed with the SEC on June 24, 2025.
Ardelyx

NASDAQ:ARDX

ARDX Rankings

ARDX Latest News

ARDX Latest SEC Filings

ARDX Stock Data

1.42B
235.83M
2.45%
70.91%
8.9%
Biotechnology
Pharmaceutical Preparations
Link
United States
FREMONT